Brand Name:

Daclata

Generic Name:

Daclatasvir

Composition:

Daclata 30mg Tablet: Each film-coated tablet contains:
Daclatasvir Dihydrochloride equivalent to Daclatasi 30mg
Daclata 60mg Tablet: Each film-coated tablet contains:
Daclatasvir Dihydrochloride equivalent to Daclatas 60mg

Description:

Daclata (Daclatasvir) is an inhibitor of HCV nonstructural protein 5A (NS5A). Daclatasvir is freely soluble in water (>700 mg/mL).

INDICATIONS:

Daclata is indicated for use with sofosbuvir for the treatment of patients with chronic hepatitis C virus (HCV) genotype 3 infection. It’s use is limited in: Sustained virologic response (SVR) rates are reduced in HCV genotype 3-infected patients with cirrhosis receiving daclatasvir in combination with sofosbuvir for 12 weeks.

PRESENTATION:

Daclata 30mg tablets: Alu. Alu. blister pack of 4 x 7’s. Daclata 60mg tablets: Alu. Alu. blister pack of 4 x 7’s.